🇺🇸 FDA
Patent

US 8597660

Therapeutic approach to neurodegenerative disorders using a TFP5-peptide

granted A61KA61K38/00A61P

Quick answer

US patent 8597660 (Therapeutic approach to neurodegenerative disorders using a TFP5-peptide) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Nov 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Dec 03 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K38/00, A61P, A61P25/00, A61P25/16